Senegal

in page functions
[French]
Total population (2014) 14,548,171
Birth cohort (2014) 543,033
Surviving Infants (surviving to 1 year per year, 2014) 516,993
Infant mortality rate (deaths < 1 year per 1000 births, 2013) 44/1000
Child mortality rate (deaths < 5 years per 1000 births, 2013) 55/1000
World Bank Index, IDA (2012) 3.68
Gross Nation Income (per capita US$, 2012) 1,040
Co-financing status (2013) Intermediate
No. of districts/territories (2013) 76

Gavi support for Senegal

Type of support

Approvals

2001-2020 (US$)
(30 Sep 2014)

Commitments

2001-2020 (US$)
(30 Sep 2014)

Disbursements

2000-2014 (US$)
(30 Sep 2014)

% Disbursed

(30 Sep 2014)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
Cash Support (CASHSUPP) $145,000 $170,000 $145,000 100%
Health system strengthening (HSS 1) $3,585,500 $3,585,500 $3,585,500 100%
HepB mono (NVS) $588,743 $588,743 $588,743 100%
HPV Demo (NVS) $146,500 $146,500 $75,301 51%
Immunisation services support (ISS) $2,605,740 $2,605,740 $2,605,740 100%
Injection safety support (INS) $619,474 $619,474 $619,474 100%
IPV (NVS) $1,384,500 $2,504,500 $91,180 7%
Measles (NVS) $543,500 $890,500 $221,169 41%
Measles-Rubella (NVS) $4,751,997 $4,751,997 $4,495,177 95%
Meningitis A - campaign (NVS) $2,670,736 $2,670,736 $2,670,736 100%
Meningitis A - operational costs (OPC) $2,567,107 $2,567,107 $2,567,107 100%
MR - Operational costs (OPC) $4,158,500 $4,158,500 $4,158,500 100%
Penta (NVS) $43,857,365 $43,857,365 $38,389,019 88%
Pneumo (NVS) $20,880,775 $28,025,775 $16,346,222 78%
Rotavirus (NVS) $3,607,500 $6,192,000 $1,264,426 35%
Vaccine Introduction Grant (VIG) $2,202,000 $2,202,000 $1,761,000 80%
Total $94,314,937 $105,536,437 $79,584,294

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Senegal DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2013)

Grade of confidence


N/A
DTP3 - Official country estimates (2013) 92%
M:F sex ratio at birth (2014) 1.04
Household survey: DTP3 coverage for male (2013) 88.90%
Household survey: DTP3 coverage for female (2013) 88.10%
Household survey: Last DTP3 survey (2013) 89%
% districts achieving > 80% DTP3 coverage (2013) 32%
% districts achieving < 50% DTP3 coverage (2013) 18%
MCV WHO/UNICEF estimates (2013) 84%
Polio WHO/UNICEF estimates (2013) 89%

Breakdown of support

Non-vaccine support Vaccine support
19% 81%
$15,018,821 $64,141,969

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Senegal

18 September 2014

Nepal IPV

Nepal becomes first country to introduce IPV with Gavi support

Nepal is one of 25 countries who have received approval to begin using IPV with Gavi support. Afghanistan and Pakistan are also planning to introduce IPV by end of next year.

29 May 2014

Seth Berkley at Canada MNCH summit

Global summit looks to immunisation to save millions of lives

Canadian PM Harper calls on countries to invest politically, financially to improve maternal, newborn and child health

08 May 2014

World Economic Forum

African leaders pledge support for immunisation

African leaders pledge to prioritise sustainable immunisation programmes as part of continued investment in the healthy futures of children and families in their countries.

close icon

modal window here